BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28550450)

  • 1. ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia.
    Mesrian Tanha H; Rahgozar S; Mojtabavi Naeini M
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):109-117. PubMed ID: 28550450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
    Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
    Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4.
    Tsukamoto M; Sato S; Satake K; Miyake M; Nakagawa H
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
    Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
    Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.
    Ansari M; Sauty G; Labuda M; Gagné V; Laverdière C; Moghrabi A; Sinnett D; Krajinovic M
    Blood; 2009 Aug; 114(7):1383-6. PubMed ID: 19515727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions.
    Banerjee M; Marensi V; Conseil G; Le XC; Cole SP; Leslie EM
    Biochem Pharmacol; 2016 Nov; 120():72-82. PubMed ID: 27659809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
    Plasschaert SL; de Bont ES; Boezen M; vander Kolk DM; Daenen SM; Faber KN; Kamps WA; de Vries EG; Vellenga E
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8661-8. PubMed ID: 16361551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
    J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
    Plasschaert SL; Vellenga E; de Bont ES; van der Kolk DM; Veerman AJ; Sluiter WJ; Daenen SM; de Vries EG; Kamps WA
    Leuk Lymphoma; 2003 Jan; 44(1):85-95. PubMed ID: 12691146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C.
    Mehrvar N; Abolghasemi H; Rezvany MR; Akbari ME; Saberynejad J; Mehrvar A; Movafagh A
    J Pediatr Hematol Oncol; 2020 Jan; 42(1):41-45. PubMed ID: 31613845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.
    Ansari M; Sauty G; Labuda M; Gagné V; Rousseau J; Moghrabi A; Laverdière C; Sinnett D; Krajinovic M
    Pharmacogenomics J; 2012 Oct; 12(5):386-94. PubMed ID: 21606946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.
    Tanaka Y; Manabe A; Fukushima H; Suzuki R; Nakadate H; Kondoh K; Nakamura K; Koh K; Fukushima T; Tsuchida M; Koike K; Kiyokawa N; Noguchi E; Sumazaki R; Komiyama T
    Pharmacogenomics J; 2015 Aug; 15(4):380-4. PubMed ID: 25403995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism analysis of CTLA-4 in childhood acute lymphoblastic leukemia.
    Hui L; Lei Z; Peng Z; Ruobing S; Fenghua Z
    Pak J Pharm Sci; 2014 Jul; 27(4 Suppl):1005-13. PubMed ID: 25016259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of -24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia.
    Sharifi MJ; Bahoush G; Zaker F; Ansari S; Rafsanjani KA; Sharafi H
    Pediatr Hematol Oncol; 2014 Mar; 31(2):169-77. PubMed ID: 24552501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.
    den Hoed MA; Lopez-Lopez E; te Winkel ML; Tissing W; de Rooij JD; Gutierrez-Camino A; Garcia-Orad A; den Boer E; Pieters R; Pluijm SM; de Jonge R; van den Heuvel-Eibrink MM
    Pharmacogenomics J; 2015 Jun; 15(3):248-54. PubMed ID: 25348617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Human ABC Transporter ABCC4 Gene SNP (rs11568658, 559 G > T, G187W) Reduces ABCC4-Dependent Drug Resistance.
    Tsukamoto M; Yamashita M; Nishi T; Nakagawa H
    Cells; 2019 Jan; 8(1):. PubMed ID: 30634695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.
    Ho LL; Kench JG; Handelsman DJ; Scheffer GL; Stricker PD; Grygiel JG; Sutherland RL; Henshall SM; Allen JD; Horvath LG
    Prostate; 2008 Sep; 68(13):1421-9. PubMed ID: 18615486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia.
    Semsei AF; Erdelyi DJ; Ungvari I; Csagoly E; Hegyi MZ; Kiszel PS; Lautner-Csorba O; Szabolcs J; Masat P; Fekete G; Falus A; Szalai C; Kovacs GT
    Cell Biol Int; 2012 Jan; 36(1):79-86. PubMed ID: 21929509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCC4 Variants Modify Susceptibility to Kawasaki Disease in a Southern Chinese Population.
    Che D; Pi L; Fang Z; Xu Y; Cai M; Fu L; Zhou H; Zhang L; Gu X
    Dis Markers; 2018; 2018():8638096. PubMed ID: 30363999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.